BERKELEY, Calif. and MAINZ, Germany, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Mainz Biomed NV (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
1 Day MYNZ 14.04% DJIA -0.75% Russell 2K -0.86% Health Care/Life Sciences 0.29% ...
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Hosted on MSN4d
ASX Quarterly Health Wrap: Blinklab starts key FDA study, Mach 7 set to meet FY25 guidanceFY25 Blinklab initiated an FDA registrational study of its Dx 1 platform as an aid in autism diagnosis, ... Read More The ...
If you're interested in exploring more stocks under $10 get an edge over other traders with Benzinga Pro while we're currently offering a 14-day trial. Investing in stocks under $10 could ...
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback